The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $46.94

Today's change+0.62 +1.34%
Updated August 22 11:38 AM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $46.94

Today's change+0.62 +1.34%
Updated August 22 11:38 AM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA crosses above 20-day moving average

Fresenius Medical Care AG & Co KGaA is up today by (U.S.)$0.62 or 1.34% to (U.S.)$46.94 and crossing above its 20-day moving average. Over the last five days, shares have gained 0.71% and 11.21% year to date. Shares have underperformed the S&P 500 by 8.46% during the last year.

Key company metrics

  • Open(U.S.) $46.75
  • Previous close(U.S.) $46.32
  • High(U.S.) $46.95
  • Low(U.S.) $46.67
  • Bid / Ask(U.S.) $46.90 / (U.S.) $46.92
  • YTD % change+11.21%
  • Volume40,686
  • Average volume (10-day)209,114
  • Average volume (1-month)179,808
  • Average volume (3-month)155,264
  • 52-week range(U.S.) $38.05 to (U.S.) $50.22
  • Beta0.48
  • Trailing P/E22.17×
  • P/E 1 year forward15.97×
  • Forward PEG1.57×
  • Indicated annual dividend(U.S.) $0.53
  • Dividend yield1.13%
  • Trailing EPS(U.S.) $2.12
Updated August 22 11:38 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.16%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue4,4714,5484,6874,598
Total other revenue--------
Total revenue4,4714,5484,6874,598
Gross profit1,4951,5921,5921,472
Total cost of revenue2,9762,9563,0953,127
Total operating expense3,8883,8973,9013,928
Selling / general / administrative881944742791
Research & development35324244
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income583651786670
Interest income (expense), net non-operating-89-121-106-110
Gain (loss) on sale of assets--------
Other--------
Income before tax488559688570
Income after tax338377476406
Income tax, total151182212164
Net income269308388333
Total adjustments to net income--------
Net income before extra. items269308388333
Minority interest-69-69-88-73
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items269308388333
Inc. avail. to common incl. extra. items269308388333
Diluted net income269308388333
Dilution adjustment----00
Diluted weighted average shares307306307307
Diluted EPS excluding extraordinary itemsvalue per share0.881.011.261.09
Dividends per sharevalue per share0.000.00----
Diluted normalized EPSvalue per share0.881.011.261.09